Lyra Therapeutics (LYRA)
(Delayed Data from NSDQ)
$5.17 USD
-0.06 (-1.15%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $5.18 +0.01 (0.19%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2024
Time: -- |
3/2024 | $-0.26 | 0.00% |
Earnings Summary
For their last quarter, Lyra Therapeutics (LYRA) reported earnings of -$0.22 per share, beating the Zacks Consensus Estimate of $-0.33 per share. This reflects a positive earnings surprise of 33.33%. Look out for LYRA's next earnings release expected on May 10, 2024. For the next earning release, we expect the company to report earnings of -$0.26 per share, reflecting a year-over-year increase of 40.91%.
Earnings History
Price & Consensus
Zacks News for LYRA
Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why
LYRA: What are Zacks experts saying now?
Zacks Private Portfolio Services